Hong Kong-listed biotech firms are outperforming as Trump’s policies cause firms to change course from their traditional US destination, with more HKEX listings expected in the second half of 2025; experts shared their views at BIOHK.
Entry deadline for the FinanceAsia Achievement Awards 2025 is now extended to September 26, 2025; the awards will celebrate the best deals and firms across Asia Pacific and the Middle East over the last 12 months.
The entry deadline for the FinanceAsia Achievement Awards 2025 has been extended to September 26; the awards will celebrate the best deals and firms across Asia Pacific and the Middle East over the last 12 months; FA's Deal Maker poll is also still open.
Cornerstone investors in the tech firm's listing include Hillhouse Investment Management, Taikang Life Insurance and Grab; net proceeds were $514m and the firm's valuation climbed above $4.6bn on its September 16 debut.
The record transaction from the Chinese insurance giant shows strong investor demand for hybrid equity instruments; the proceeds will be used for AI and international expansion.